Simple drug regimen cures hepatitis C virus in patients after 12 weeks

Researchers have found that a simple drug regimen delivered over 12 weeks achieved sustained eradication of several genotypes of the hepatitis C virus (HCV) in 99 per cent of the trial's patients.